More than a third of anti-malarial drugs available in Sub-Saharan Africa and Southeast Asia are counterfeit or substandard, according to the FDA. For this reason, the agency announced Wednesday its plans to implement a tool called the Counterfeit Detector Device, or CD-3, to better enable agencies and organizations to differentiate between real and fake medication.
The Food and Drug Administration (FDA) announced Tuesday that it will not approve generic forms of OxyContin and that, going forward, it will only allow the production and sale of the 2010 form of the drug, which was specially designed to mitigate the abuse of it.
House Democrats led by Rep. Ed Markey, D-Mass., released a report Monday highlighting a lack of oversight of compounding pharmacies like the one responsible for the outbreak of fungal meningitis last year that killed 53 people and sickened 733.
Dietary stimulants containing the stimulant DMAA have got to go, warned the Food and Drug Administration (FDA) in a press release on Friday.